Dr Geraldine Venthoye

Executive Vice President Pharmaceutical Development

Dr Geraldine Venthoye was appointed Vice President Pharmaceutical Development in February 2012, having joined the Company as Head of Inhalation Business Unit in September 2003. Previously, she had held senior CMC leadership and scientific roles in Inhale/Nektar Therapeutics, San Carlos, California, US. Prior to this in the UK she held scientific positions in inhalation drug delivery at Vandsons Research and Norton Healthcare.

Dr Venthoye is a UK registered pharmacist and holds a doctorate degree in Pharmaceutics from the University of London. In 2011, Dr Venthoye was appointed Affiliate Assistant Professor in the Department of Pharmaceutics, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, US.


Dr Geraldine Venthoye Dr Geraldine Venthoye

> Executive management

Copyright 2014, Skyepharma. All Rights Reserved. Skyepharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 46-48 Grosvenor Gardens, London SW1W 0EB, United Kingdom

Contact addresses

Skyepharma PLC
46-48 Grosvenor Gardens
London
SW1W 0EB
UK

Tel: +44 207 881 0524

Fax: +44 207 881 1199

E-mail us

Skyepharma AG
Eptingerstrasse 61
4132 Muttenz
Switzerland

Tel: +41 61 467 5555

Fax: +41 61 467 5500

E-mail us

This website works best using cookies.